ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GCOR Genencor International, (MM)

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Genencor International, (MM) NASDAQ:GCOR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Genencor International, Inc. Invites You to Join its Fourth Quarter and Year-End Earnings Conference Call on the Web

20/01/2005 9:00pm

PR Newswire (US)


Genencor International (NASDAQ:GCOR)
Historical Stock Chart


From Nov 2019 to Nov 2024

Click Here for more Genencor International Charts.
Genencor International, Inc. Invites You to Join its Fourth Quarter and Year-End Earnings Conference Call on the Web PALO ALTO, Calif., Jan. 20 /PRNewswire-FirstCall/ -- In conjunction with Genencor International, Inc.'s (NASDAQ:GCOR) fourth quarter and year-end earnings press release, you are invited to listen to its conference call that will be broadcast live over the Internet on February 10, 2005 at 5:00 p.m., EST, with Jean-Jacques Bienaime, Chairman, Chief Executive Officer and President and Raymond J. Land, Senior Vice President and Chief Financial Officer. What: Genencor International, Inc.'s Fourth Quarter and Year-End Earnings Conference Call When: Thursday, February 10, 2005 at 5:00 p.m. EST Where: http://www.shareholder.com/genencor/medialist.cfm How: Live over the Internet -- Simply log on to the Web at the address listed above or dial-in to 800-230-1085 (domestic) and 612-288-0318 (international). About Genencor Genencor International, Inc. (http://www.genencor.com/) is a diversified biotechnology company that develops and delivers innovative products and services into the health care, agri-processing, industrial and consumer markets. Using an integrated set of technology platforms, Genencor's products deliver innovative and sustainable solutions to improve the quality of everyday life. Genencor traces its history to 1982 and has grown to become a leading biotechnology company, with over $380 million in year 2003 annual revenues. Genencor has principal offices in Palo Alto, California; Rochester, New York; and Leiden, the Netherlands. Genencor's fourth quarter and year-end earnings release will be issued on February 10, 2005 at 4:00 p.m. EST and will be made available in the Press Center section of the company's website, http://www.genencor.com/. If you are unable to participate during the live webcast, the call will be posted in the Investor Relations section of the website beginning February 10, 2005 at 8:30 p.m. EST. In addition, the digitized replay may be accessed until February 24, 2005 by dialing 800-475-6701 (domestic) or 320-365-3844 (international), access code #765673. The company will archive the earnings release audio replay as well as the press release on the company's website. (Minimum Requirements to listen to broadcast: The RealPlayer software, downloadable free from http://www.real.com/products/player/index.html , and at least a 14.4Kbps connection to the Internet. If you experience problems listening to the broadcast, send an e-mail to .) DATASOURCE: Genencor International, Inc. CONTACT: Ruey-Li Hwang of Genencor International, Inc., +1-650-846-7676 Web site: http://www.genencor.com/

Copyright

1 Year Genencor International Chart

1 Year Genencor International Chart

1 Month Genencor International Chart

1 Month Genencor International Chart